Parexel International Corporation

About Parexel International Corporation

Parexel provides global biopharmaceutical services, managing Phase I-IV clinical trials, regulatory consulting, market access, and real-world evidence studies for drug and device development. The company supports sponsors in trial design, site selection, patient recruitment, data management, biostatistics, pharmacovigilance, and health economics. Operating in over 100 countries, Parexel integrates therapeutic expertise with technology platforms to accelerate approvals and improve evidence generation. Services span oncology, neurology, rare diseases, and vaccines, combining decentralized trial capabilities, digital health tools, and post-marketing surveillance to optimize development timelines and commercial success.